PacBio to Present at Upcoming Investor Conferences
Get Alerts PACB Hot Sheet
Join SI Premium – FREE
MENLO PARK, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be participating in the following upcoming investor conferences:
- Wolfe Research Healthcare Conference 2025 in New York, NY
Fireside chat on Tuesday, November 18 at 8:40 AM ET
- Jefferies Global Healthcare Conference in London, UK
Hosting 1x1 meetings only on Wednesday, November 19
- Stephens Annual Investment ConferenceĀ in Nashville, TN
Fireside chat on Wednesday, November 19 at 10:00 AM CT
Live webcasts of the fireside chats can be accessed at the company's investors page at investor.pacificbiosciences.com. Webcast replays will be available for at least 30 days following the event.
About PacBio
PacBio (NASDAQ: PACB) is a premier life science technology company that designs, develops, and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Our products and technologies, which include our HiFi long-read sequencing, address solutions across a broad set of research applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. For more information, please visit www.pacb.com and follow @PacBio.
PacBio products are provided for Research Use Only. Not for use in diagnostic procedures.
Contacts
Investors:
[email protected]
Media:
[email protected]
Source: PacBio
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jura Announces Commencement of Drilling in Maru Lease
- NY-21 Republican County Chairs Endorse Anthony Constantino for Congress
- UPDATE: Rogers Sugar Announces Extention of Collective Agreement at Taber Refinery
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share